Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moderna Inc 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 USA

P: 617-714-6500 F: 617-583-1998

Description:

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 61,847,340
Shares Outstanding, K 405,450
Annual Sales, $ 803,400 K
Annual Net Income, $ -747,060 K
Last Quarter Sales, $ 4,969 M
Last Quarter Net Income, $ 3,333 M
60-Month Beta 1.22
% of Insider Shareholders 19.40%
% of Institutional Shareholders 59.11%
Float, K 326,793
% Float 80.60%

Growth:

1-Year Return 1.99%
3-Year Return 855.36%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 7.70 on 11/04/21
Next Earnings Date 02/24/22
Earnings Per Share ttm 16.31
EPS Growth vs. Prev Qtr 19.20%
EPS Growth vs. Prev Year 1,405.08%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MRNA Ratios

Ratio
Price/Earnings ttm 9.64
Price/Earnings forward 0.00
Price/Earnings to Growth 0.92
Return-on-Equity % 121.61%
Return-on-Assets % 49.46%
Profit Margin % -92.99
Net Margin % -882.60
Debt/Equity 0.02
Price/Sales 5.53
Price/Cash Flow N/A
Price/Book 6.30
Book Value/Share 24.97
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar